Category: Biotechnology
Biotechnology market research reports by Plunkett Research, Ltd.
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save co ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199
Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and fore ... Read More
-
Plunkett's Health Care Industry Almanac 2025: Health Care Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S HEALTH CARE INDUSTRY ALMANAC 2025 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Health Care Industry. Gain vital insights that can help shape strategy for business developme ... Read More
-
Financial Analysis and Multi-Year Benchmarking: ImmunoPrecise Antibodies Ltd (IPA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: ImmunoPrecise Antibodies Ltd (IPA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forImmunoPrecise Antibodies Ltd ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Replicel Life Sciences Inc (RP:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Replicel Life Sciences Inc (RP:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forReplicel Life Sciences Inc (RP: ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lexaria Bioscience Corp (LEXX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lexaria Bioscience Corp (LEXX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings This unique new report provides deep financial benchmarks forLexaria Bioscience Corp (LEXX:NA ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2025: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S BIOTECH, PHARMACEUTICALS & GENETICS INDUSTRY ALMANAC 2025 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights tha ... Read More
-
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325414
Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325414 Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmark ... Read More
-
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412
Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325412 Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Metrics, Ben ... Read More
-
Basic Organic Chemical Manufacturing, Including Petrochemical Intermediates, Silicone, Ethanol, Plasticizers and Enzyme Proteins (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325190
Basic Organic Chemical Manufacturing, Including Petrochemical Intermediates, Silicone, Ethanol, Plasticizers and Enzyme Proteins (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 325190 Basic Organic Chemical Manufacturing, Including Petrochemical Interme ... Read More
-
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710 Scientific Research and Development (R&D) in Physics, Engineering, Life Sc ... Read More
-
Miromatrix Medical Inc (MIRO:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Miromatrix Medical Inc (MIRO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Miromatrix Medical Inc (MIRO:NAS) compared to its top competitors and compared ... Read More
-
Caribou Biosciences Inc (CRBU:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Caribou Biosciences Inc (CRBU:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Caribou Biosciences Inc (CRBU:NAS) compared to its top competitors and compar ... Read More
-
Natera Inc (NTRA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Natera Inc (NTRA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Natera Inc (NTRA:NAS) compared to its top competitors and compared to the average for all ... Read More
-
Charles River Laboratories International Inc (CRL:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Charles River Laboratories International Inc (CRL:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Charles River Laboratories International Inc (CRL:NYS) co ... Read More
-
Agilent Technologies Inc (A:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Agilent Technologies Inc (A:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Agilent Technologies Inc (A:NYS) compared to its top competitors and compared t ... Read More
-
908 Devices Inc (MASS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
908 Devices Inc (MASS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for 908 Devices Inc (MASS:NAS) compared to its top competitors and compared to the averag ... Read More
-
Regeneron Pharmaceuticals Inc (REGN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Regeneron Pharmaceuticals Inc (REGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Regeneron Pharmaceuticals Inc (REGN:NAS) compared to its top competitor ... Read More
-
Cerus Corporation (CERS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Cerus Corporation (CERS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Cerus Corporation (CERS:NAS) compared to its top competitors and compared to the av ... Read More
-
Fortress Biotech (FBIO:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Fortress Biotech (FBIO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Fortress Biotech (FBIO:NAS) compared to its top competitors and compared to the aver ... Read More
-
Northwest Biotherapeutics Inc (NWBO:PINX): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Northwest Biotherapeutics Inc (NWBO:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Northwest Biotherapeutics Inc (NWBO:PINX) compared to its top competit ... Read More
-
Agenus Inc (AGEN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Agenus Inc (AGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Agenus Inc (AGEN:NAS) compared to its top competitors and compared to the average for all ... Read More
-
Lineage Cell Therapeutics Inc (LCTX:ASE): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Lineage Cell Therapeutics Inc (LCTX:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Lineage Cell Therapeutics Inc (LCTX:ASE) compared to its top competitor ... Read More
-
ADMA Biologics Inc (ADMA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for ADMA Biologics Inc (ADMA:NAS) compared to its top competitors and compared to the ... Read More
-
Myriad Genetics Inc (MYGN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Myriad Genetics Inc (MYGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Myriad Genetics Inc (MYGN:NAS) compared to its top competitors and compared to th ... Read More
Research Assistance
